Our data suggest PCK2 regulates tumor initiation of prostate cancer cells by reducing the mitochondrial tricarboxylic acid (TCA) cycle activity and thereby production of citrate and acetyl-CoA. The gene discussed is PCK2; the disease is prostate carcinoma.